Real-time enrollment status for this macular degeneration clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 7:18 AM UTC
| NCT Number | NCT04853251 |
| Recruiting Status | Recruiting |
| Condition | Macular Degeneration |
| Phase | Clinical Trial |
| Target Enrollment | 188 participants |
| Active Locations | 50 sites in the US |
| Sponsor | Genentech, Inc. |
| Last Updated on CT.gov | February 13, 2026 (2 weeks ago) |
As of March 2, 2026: Clinical trial NCT04853251 is currently recruiting participants. This clinical trial study for macular degeneration is actively seeking new participants at 50 locations across the United States. The study is sponsored by Genentech, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04853251 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 50 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04853251 was last updated 2 weeks ago (February 13, 2026). HelloStudys verifies this status automatically.